Table of Contents
Volume 8, Issue 11
June 1, 2009
Pages 987 - 1084
Editor's Corner
-
Cover caption
News
-
Daiichi Sankyo and MorphoSys expand collaboration with two new cancer-related antibody programs
-
Research sheds new light on why pancreatic cancer drugs fail
-
M.D. Anderson Study Finds Dramatic Increase in Metastatic Colon Cancer Survival
-
UNC scientists identify growth factor as possible cancer drug target
-
Landmark UNC-led study finds radiofrequency ablation is effective treatment for Barrett’s esophagus
-
Gene Mutation Marks Aggressive Endometrial Cancer
Review
-
Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors
Changguo Chen, Dan Li and Ning Guo
Pages 987 - 995
Clinical Study
-
Muc 2 but not muc 5 expression correlates with prognosis in radically resected pancreatic cancer patients
Pantano Francesco, Baldi Alfonso, Santini Daniele, Vincenzi Bruno, Borzomati Domenico, Vecchio Fabio Maria, Castri Federica, Antinori Armando, Michele Caraglia, Magistrelli Paolo, Coppola Roberto and Tonini Giuseppe
Pages 996 - 999
Commentary
-
MUC2 a new key for pancreas cancer prognosis
Addeo Raffaele, Alberto Abbruzzese and Salvatore Del Prete
Pages 1000 - 1001
Research Papers
-
Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo
Yanchao Fu, Qingyu Zhang, Chunsheng Kang, Jing Zhang, Kairu Zhang, Peiyu Pu, Guangxiu Wang and Tao Wang
Pages 1002 - 1009
-
A human bone NOD/SCID mouse model to distinguish metastatic potential in primary breast cancers
Pearl Lam, Wenyi Yang, Yutaka Amemiya, Harriette Kahn, Albert Yee, Claire Holloway and Arun Seth
Pages 1010 - 1017
-
Down-regulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro
Baofeng Wang, Lin Han, Rudong Chen, Mingjun Cai, Fuxin Han, Ting Lei and Dong-Sheng Guo
Pages 1018 - 1023
Commentary
-
RIGging functional outcomes in glioma cells: New insights into LRIG proteins in malignant gliomas
David D. Eisenstat and Spencer B. Gibson
Pages 1024 - 1026
Research Papers
-
Dual targeting of EphA2 and FAK in ovarian carcinoma
Mian M.K. Shahzad, Chunhua Lu, Jeong-Won Lee, Rebecca L. Stone, Rahul Mitra, Lingegowda S. Mangala, Yiling Lu, Keith A. Baggerly, Christopher G. Danes, Alpa M. Nick, Jyotsnabaran Halder, Hye-Sun Kim, Pablo Vivas-Mejia, Charles N Landen, Gabriel Lopez-Berestein, Robert L Coleman and Anil K. Sood
Pages 1027 - 1034
-
A novel antibody fragment targeting HAb18G/CD147 with cytotoxicity and decreased immunogenicity
Hongbin Zhu, Bin Yang, Xiangmin Yang, Li Wang, Jun Xu, Chenggong Liao, Qiang Feng, Hao Tang, Ling Hu, Zhinan Chen and Yu Li
Pages 1035 - 1044
-
ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation
Xuguang Zheng, Feng Jiang, Mark Katakowski, Zheng Gang Zhang, Qing-e Lu and Michael Chopp
Pages 1045 - 1054
Commentary
-
ADAM17: The new face of breast cancer-promoting metalloprotease activity
Kristine Glunde and Ioannis Stasinopoulos
Pages 1055 - 1057
Research Papers
-
Inhibiting gastric cancer-associated angiogenesis by CIAPIN1 siRNA
Kun Yan, Li-jie He, Wei Cheng, Zong-zheng Ji, Bin-xiu Zhao, Xiao-li Hui, Shan-sha Cao, Bei Chen, Li He, Shu-hui Lang and Yv Miao
Pages 1058 - 1063
-
Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression
Zhiming Hao, Xiaohua Li, Taidong Qiao, Shuang Li, Yifei Lv and Daiming Fan
Pages 1064 - 1070
-
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
Open Access Article
Agnieszka Witkiewicz, Abhijit Dasgupta, Katherine Nguyen, Chengbao Liu, Albert J. Kovatich, Gordon F. Schwartz, Richard G. Pestell, Federica Sotgia, Hallgeir Rui and Michael P. Lisanti
Pages 1071 - 1079